Основные аспекты этиопатогенеза окклюзий вен сетчатки у лиц молодого возраста. Часть I. Нейроретиноваскулиты (протромботический потенциал, клинические проявления)

Обложка

Цитировать

Полный текст

Аннотация

Обзор литературы посвящён нейроретиноваскулиту, как ведущей причине окклюзии вен сетчатки у лиц молодого возраста. Рассмотрены предполагаемые этиологические факторы, возможные механизмы патогенеза и клиническая картина данного заболевания. Обоснованы целесообразность мультидисциплинарного подхода к ведению и индивидуальный подход в лечении пациентов с нейроретиноваскулитом со вторичной ОВС.

Об авторах

Светлана Николаевна Тульцева

ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова» Минздрава России

Автор, ответственный за переписку.
Email: tultceva@yandex.ru

д-р мед. наук, профессор кафедры офтальмологии

Россия, Санкт-Петербург

Алла Борисовна Лисочкина

ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова» Минздрава России

Email: alan05@bk.ru

канд. мед. наук, доцент кафедры офтальмологии

Россия, Санкт-Петербург

Александра Ивановна Титаренко

ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова» Минздрава России

Email: Aleksandra-titarenko@yandex.ru

аспирант кафедры офтальмологии

Россия, Санкт-Петербург

Вадим Алексеевич Тургель

ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова» Минздрава России

Email: zanoza194@gmail.com

студент, кафедра офтальмологии

Россия, Санкт-Петербург

Список литературы

  1. Астахов Ю.С., Петрищев Н.Н., Варганова Т.С., Тульцева С.Н. Тромбофилии в патогенезе тромбоза ретинальных вен // Вестник офтальмологии. – 2008. – Т. 124. – № 3. – С. 56–58. [Asta khov YS, Petrishchev NN, Varganova TS, Tultseva SN. Thrombophilia in the pathogenesis of retinal vein thrombosis. Annals of ophthalmology. 2008;124(3):56-58. (In Russ.)]
  2. Нероев В.В., Танковский В.Э., Григорьев А.В., и др. Влияние однократного интравитреального введения бевацизумаба на остроту зрения и агрегацию тромбоцитов у больных с тромбозом вен сетчатки на фоне ангиита // Российский офтальмологический журнал. – 2013. – Т. 6. – № 3. – С. 67–70. [Neroev VV, Tankov skiy VE, Grigoryev AV, et al. The Changes of Visual Acuity and Platelet Aggregation in Patients with Retinal Vein Occlusion Accompanied by Angiitis after a Single Intravitreal Injection of Bevacizumab. Rossiiskii oftalmologicheskii zhurnal. 2013;6(3):67-70. (In Russ.)]
  3. Танковский В.Э. Тромбозы вен сетчатки. – М.: Воениздат, 2000. [Tankovskiy VE. Retinal vein thrombosis. Moscow: Voenizdat; 2000. (In Russ.)]
  4. Тульцева С.Н. Тромбофилия как фактор риска развития тромбозов центральной вены сетчатки у лиц молодого возраста // Офтальмологические ведомости. – 2008. – Т. 1. – № 1. – С. 46–51. [Tultseva SN. Thrombophilia as a Risk Factor of Central Retinal Vein Thrombosis Development among Young People. Ophthalmology Journal. 2008;1(1):46-51. (In Russ.)]
  5. Астахов Ю.С., Тульцева С.Н. Этиологические факторы развития тромбоза вен сетчатки у пациентов молодого возраста // Регионарное кровообращение и микроциркуляция. – 2004. – Т. 3. – № 4. – С. 39–42. [Astakhov YS, Tultseva SN. Etiological factors of retinal vein thrombosis development in young patients. Regionarnoe krovoobrashchenie i mikrotsirkuliatsiia. 2004;3(4):39-42. (In Russ.)]
  6. Тульцева С.Н. Значение гипергомоцистеинемии в патогенезе ишемического тромбоза вен сетчатки // Офтальмологические ведомости. – 2008. – Т. 1. – № 3. – С. 31–40. [Tultseva SN. The Significance of Hyperhomocysteinemia in the Pathogenesis of the Ischemic Thrombosis of Retinal Veins. Ophthalmology Journal. 2008;1(3):31-40. (In Russ.)]
  7. Abu El-Asrar AM, Al-Obeidan SA, Abdel Gader AGM. Retinal Periphlebitis Resembling Frosted Branch Angiitis with Nonperfused Central Retinal Vein Occlusion. Eur J Ophthalmol. 2018;13(9-10):807-812. doi: 10.1177/1120672103013009-1015.
  8. El-Asrar AM, Herbort CP, Tabbara KF. A clinical approach to the diagnosis of retinal vasculitis. Int Ophthalmol. 2010;30(2):149-73. doi: 10.1007/s10792-009-9301-3.
  9. Abu El-Asrar AM, Herbort CP, Tabbara KF. Differential diagnosis of retinal vasculitis. Middle East Afr J Ophthalmol. 2009;16(4):202-18. doi: 10.4103/0974-9233.58423.
  10. Abu El-Asrar AM, Herbort CP, Tabbara KF. Retinal vasculitis. Ocul Immunol Inflamm. 2005;13(6):415-433. doi: 10.1080/
  12. Al-Mezaine HS, Al-Muammar A, Kangave D, Abu El-Asrar AM. Clinical and optical coherence tomographic findings and outcome of treatment in patients with presumed tuberculous uveitis. Int Ophthalmol. 2008;28(6):413-423. doi: 10.1007/s10792-007-9170-6.
  13. Appen RE, de Venecia G, Ferwerda J. Optic Disk Vasculitis. Am J Ophthalmol. 1980;90(3):352-359. doi: 10.1016/s0002-9394(14)74916-5.
  14. Biswas J, Ravi RK, Naryanasamy A, et al. Eales' disease – current concepts in diagnosis and management. J Ophthalmic Inflamm Infect. 2013;3(1):11. doi: 10.1186/1869-5760-3-11.
  15. Biswas J, Sharma T, Gopal L, et al. Eales Disease – An Update. Surv Ophthalmol. 2002;47(3):197-214. doi: 10.1016/s0039-6257(02)00288-6.
  16. Bodaghi B, Rozenberg F, Cassoux N, et al. Nonnecrotizing herpetic retinopathies masquerading as severe posterior uveitis. Ophthalmology. 2003;110(9):1737-1743. doi: 10.1016/s0161-6420(03)00580-3.
  17. Chang YC, Wu WC. Intravitreal triamcinolone acetonide for the management of papillophlebitis and associated macular edema. Int Ophthalmol. 2008;28(4):291-296. doi: 10.1007/s10792-007-9128-8.
  18. Cogan D. Retinal and Papillary Vasculitis. In: The Witham Mackenzie Centenary Symposium on Ocular Circulations and Disease. St. Louis: CV Mosby; 1969. P. 249-270.
  19. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990;335(8697):1078-1080.
  20. Deobhakta A, Chang LK. Inflammation in retinal vein occlusion. Int J Inflam. 2013;2013:438412. doi: 10.1155/2013/438412.
  21. Di Capua M, Coppola A, Albisinni R, et al. Cardiovascular risk factors and outcome in patients with retinal vein occlusion. J Thromb Thrombolysis. 2010;30(1):16-22. doi: 10.1007/s11239-009-0388-1.
  22. Duker JS, Sergott RC, Savino PJ, Bosley TM. Optic Neuritis with Secondary Retinal Venous Stasis. Ophthalmology. 1989;96(4):475-480. doi: 10.1016/s0161-6420(89)32871-5.
  23. Ehlers JP, Fekrat S. Retinal vein occlusion: beyond the acute event. Surv Ophthalmol. 2011;56(4):281-299. doi: 10.1016/j.survophthal.2010.11.006.
  24. Emmi G, Silvestri E, Squatrito D, et al. Thrombosis in vasculitis: from pathogenesis to treatment. Thromb J. 2015;13:15. doi: 10.1186/s12959-015-0047-z.
  25. Esmon CT. Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev. 2009;23(5):225-229. doi: 10.1016/j.blre.2009.07.002.
  26. Figueiredo L, Rothwell R, Brandao A, Fonseca S. Central retinal vein occlusion in a patient with retinal vasculitis and Crohn's disease. Case Rep Ophthalmol Med. 2014;2014:967878. doi: 10.1155/
  27. /967878.
  28. Flammer J, Konieczka K. Retinal venous pressure: the role of endothelin. EPMA J. 2015;6:21. doi: 10.1186/s13167-015-0043-1.
  29. Fong AC, Schatz H, McDonald HR, et al. Central retinal vein occlusion in young adults (papillophlebitis). Retina. 1992;12(1):3-11.
  30. Fong ACO, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol. 1993;37(6):393-417. doi: 10.1016/0039-6257(93)90138-w.
  31. Garcia-Diaz M, Mira M, Nevado L, et al. Retinal vasculitis associated with Crohn's disease. Postgrad Med J. 1995;71(833):170-2. doi: 10.1136/pgmj.71.833.170.
  32. Gass JDM, Olson CL. Sarcoidosis With Optic Nerve and Retinal Involvement. Arch Ophthalmol. 1976;94(6):945-950. doi: 10.1001/archopht.1976.03910030475008.
  33. Ghadiali Q, Ghadiali LK, Yannuzzi LA. Bartonella Henselae Neuroretinitis Associated with Central Retinal Vein Occlusion, Choroidal Ischemia, and Ischemic Optic Neuropathy. Retin Cases Brief Rep. 2017. doi: 10.1097/ICB.0000000000000612.
  34. Glueck CJ, Ping W, Hutchins R, et al. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions. Clin Appl Thromb Hemost. 2008;14(3):286-294. doi: 10.1177/1076029607304726.
  35. Gray AV, Michels KS, Lauer AK, Samples JR. Bartonella henselae infection associated with neuroretinitis, central retinal artery and vein occlusion, neovascular glaucoma, and severe vision loss. Am J Ophthalmol. 2004;137(1):187-189. doi: 10.1016/s0002-9394(03)00784-0.
  36. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc. 1981;79:371-422.
  37. Greifner G, Neri P, Amer R. Frosted branch angiitis complicated by retinal vein occlusion: clinical course and long-term visual outcome. Graefes Arch Clin Exp Ophthalmol. 2016;254(3):541-544. doi: 10.1007/s00417-015-3255-0.
  38. Grosso A, Calzada JI, Randolph J, Sigler E. Papillophlebitis: a closer look. Retina Today. 2017;12(5):32-38.
  39. Guex-Crosier Y, Pittet N, Herbort CP. Sensitivity of Laser Flare Photometry to Monitor Inflammation in Uveitis of the Posterior Segment. Ophthalmology. 1995;102(4):613-621. doi: 10.1016/s0161-6420(95)30976-1.
  40. Harold Lee HB, Pulido JS, McCannel CA, Buettner H. Role of inflammation in retinal vein occlusion. Can J Ophthalmol. 2007;42(1):131-133. doi: 10.3129/can.j.ophthalmol.06-101.
  41. Hart D, Miller S. Benign Retinal Vasculitis. Br J Ophthalmol. 1971;55:721-733.
  42. Hayreh SS. Optic disc vasculitis. Br J Ophthalmol. 1972;56(9):
  43. -670. doi: 10.1136/bjo.56.9.652.
  44. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol. 2001;131(1):61-77. doi: 10.1016/s0002-9394(00)00709-1.
  45. Hoyt W. A Syndrome of Unilateral Disc Swelling, Enlarged Blind Spot and Photopsia. In: Proceedings of the 2nd Congress of the International Society of Neuro-Ophthalmology; 1978 May 1; Airlie House.
  46. Hughes EH, Dick AD. The pathology and pathogenesis of retinal vasculitis. Neuropathol Appl Neurobiol. 2003;29(4):325-340. doi: 10.1046/j.1365-2990.2003.00499.x.
  47. Kuo JZ, Lai CC, Ong FS, et al. Central retinal vein occlusion in a young Chinese population: risk factors and associated morbidity and mortality. Retina. 2010;30(3):479-484. doi: 10.1097/IAE.0b013e3181b9b3a0.
  48. Kalogeropoulos CD, Bassukas ID, Moschos MM, Tabbara KF. Eye and Periocular Skin Involvement in Herpes Zoster Infection. Med Hypothesis Discov Innov Ophthalmol. 2015;4(4):142-156.
  49. Karia N. Retinal vein occlusion: pathophysiology and treatment options. Clin Ophthalmol. 2010;4:809-816.
  50. Karska-Basta I, Kubicka-Trzaska A, Romanowska-Dixon B, Undas A. Thrombophilia – a risk factor of retinal vein occlusion? Klin Oczna. 2013;115(1):29-33.
  51. Albert K, Masset M, Bonnet S, et al. Long-term follow-up of herpetic non-necrotizing retinopathy with occlusive retinal vasculitis and neovascularization. J Ophthalmic Inflamm Infect. 2015;5:6. doi: 10.1186/s12348-015-0038-z.
  52. Kim JY, Lee JH, Lee CS, Lee SC. Varicella zoster virus-associated Chorioretinitis: a case report. BMC Ophthalmol. 2018;18(1):28. doi: 10.1186/s12886-018-0696-3.
  53. Kolar P. Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data. J Ophthalmol. 2014;2014:724780. doi: 10.1155/2014/724780.
  54. Kumawat B, Tripathy K, Venkatesh P, et al. Central Retinal Vein Occlusion-like Appearance: A Precursor Stage in Evolution of Frosted Branch Angiitis. J Ophthalmic Vis Res. 2017;12(4):
  55. -442. doi: 10.4103/jovr.jovr_84_15.
  56. López JA, Chen J. Pathophysiology of venous thrombosis. Thromb Res. 2009;123:S30-S34. doi: 10.1016/s0049-3848(09)70140-9.
  57. Lyle TK, Wybar K. Retinal Vasculitis. Br J Ophthalmol. 1961;45(12):778-788. doi: 10.1136/bjo.45.12.778.
  58. Madhavan HN, Therese KL, Gunisha P, et al. Polymerase chain reaction for detection of Mycobacterium tuberculosis in epiretinal membrane in Eales' disease. Invest Ophthalmol Vis Sci. 2000;41(3):822-825.
  59. Maugeri N, Baldini M, Ramirez GA, et al. Platelet-leukocyte deregulated interactions foster sterile inflammation and tissue damage in immune-mediated vessel diseases. Thromb Res. 2012;129(3):267-273. doi: 10.1016/j.thromres.2011.12.001.
  60. McDonald WI, Barnes D. The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry. 1992;55(9):747-752.
  61. Stanford MR, Verity DH. Diagnostic and therapeutic approach to patients with retinal vasculitis. Int Ophthalmol Clin. 2000;40(2):69-83.
  62. Miserocchi E, Modorati G, Azzolini C, et al. Herpes Simplex Virus Type 2 Acute Retinal Necrosis in an Immunocompetent Patient. Eur J Ophthalmol. 2018;13(1):99-102. doi: 10.1177/112067210301300118.
  63. Nakao K, Ohba N. Human T-Cell Lymphotropic Virus Type 1-Associated Retinal Vasculitis in Children. Retina. 2003;23(2):197-201. doi: 10.1097/00006982-200304000-00010.
  64. Nguyen ML, Blaho JA. Apoptosis During Herpes Simplex Virus Infection. Adv Virus Res. 2006;69:67-97. doi: 10.1016/s0065-3527(06)69002-7.
  65. Odeberg J, Wolmer N, Falci S, et al. Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J Virol. 2006;80(18):8929-8939. doi: 10.1128/JVI.00676-06.
  66. Okada AA. Drug therapy in Behçet's disease. Ocul Immunol Inflamm. 2009;8(2):85-91. doi: 10.1076/0927-3948(200006)821-0ft085.
  67. Paovic J, Paovic P, Sredovic V. Behcet's disease: systemic and ocular manifestations. Biomed Res Int. 2013;2013:247345. doi: 10.1155/2013/247345.
  68. Papadia M, Misteli M, Jeannin B, Herbort CP. The influence of anti-VEGF therapy on present day management of macular edema due to BRVO and CRVO: a longitudinal analysis on visual function, injection time interval and complications. Int Ophthalmol. 2014;34(6):1193-1201. doi: 10.1007/s10792-014-0002-1.
  69. Patte M, Rouher FN, Vernay D, et al. Proliferative retinal vasculitis and multiple sclerosis: a case report. J Fr Ophtalmol. 2003;26(4):381-385.
  70. Quillen DA, Stathopoulos NA, Blankenship GW, Ferriss JA. Lupus Associated Frosted Branch Periphlebitis and Exudative Maculopathy. Retina. 1997;17(5):449-451. doi: 10.1097/00006982-199709000-00016.
  71. Rehak M, Rehak J, Muller M, et al. The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis. Thromb Haemost. 2008;99(5):925-929. doi: 10.1160/TH07-11-0658.
  72. Rehak M, Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost. 2010;8(9):1886-1894. doi: 10.1111/j.1538-7836.2010.03909.x.
  73. Rochat C, Polla BS, Herbort CP. Immunological profiles in patients with acute retinal necrosis. Graefes Arch Clin Exp Ophthalmol. 1996;234(9):547-552. doi: 10.1007/bf00448798.
  74. Rosen PH, Spalton DJ, Graham EM. Intraocular tuberculosis. Eye (Lond). 1990;4(Pt 3):486-492. doi: 10.1038/eye.1990.63.
  75. Sharief L, Lightman S, Blum-Hareuveni T, et al. Clinical Outcome of Retinal Vasculitis and Predictors for Prognosis of Ischemic Retinal Vasculitis. Am J Ophthalmol. 2017;177:206-212. doi: 10.1016/j.ajo.2017.02.028.
  76. Singh R, Toor P, Parchand S, et al. Quantitative polymerase chain reaction for Mycobacterium tuberculosis in so-called Eales' disease. Ocul Immunol Inflamm. 2012;20(3):153-157. doi: 10.3109/09273948.2012.658134.
  77. Sofi F, Marcucci R, Bolli P, et al. Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. Atherosclerosis. 2008;198(1):223-227. doi: 10.1016/j.atherosclerosis.2007.09.009.
  78. Springer J, Villa-Forte A. Thrombosis in vasculitis. Curr Opin Rheumatol. 2013;25(1):19-25. doi: 10.1097/BOR.0b013e32835ad3ca.
  79. Sinawat S, Bunyavee C, Ratanapakorn T, et al. Systemic abnormalities associated with retinal vein occlusion in young patients. Clin Ophthalmol. 2017;11:441-447. doi: 10.2147/OPTH.S128341.
  80. Sykes SO, Horton JC. Steroid-Responsive Retinal Vasculitis with a Frosted Branch Appearance in Crohns Disease. Retina. 1997;17(5):451-454. doi: 10.1097/00006982-199709000-00017.
  81. Tajunisah I, Reddy SC, Tan LH. Acute retinal necrosis by cytomegalovirus in an immunocompetent adult: case report and review of the literature. Int Ophthalmol. 2009;29(2):85-90. doi: 10.1007/s10792-007-9171-5.
  82. Talat L, Lightman S, Tomkins-Netzer O. Ischemic retinal vasculitis and its management. J Ophthalmol. 2014;2014:197675. doi: 10.1155/2014/197675.
  83. Taylor SR, Singh J, Menezo V, et al. Behcet disease: visual prognosis and factors influencing the development of visual loss. Am J Ophthalmol. 2011;152(6):1059-1066. doi: 10.1016/j.ajo.2011.05.032.
  84. Trese MGJ, Yonekawa Y, Thomas BJ, Randhawa S. Vasculitic central retinal vein occlusion: The presenting sign of seronegative rheumatoid arthritis. Am J Ophthalmol Case Rep. 2016;2:26-29. doi: 10.1016/j.ajoc.2016.04.007.
  85. Tugal-Tutkun I, Yalçındağ FN, Herbort CP. Laser flare photometry and its use in uveitis. Expert Rev Ophthalmol. 2014;7(5):449-457. doi: 10.1586/eop.12.47.
  86. Turner SJ, Dharmasena A, Deane J. Bilateral rubeosis iridis and rubeotic glaucoma due to peripheral occlusive vasculitis associated with multiple sclerosis. Ocul Immunol Inflamm. 2011;19(5):
  87. -375. doi: 10.3109/09273948.2011.602500.
  88. Verity DH. Behcet's disease: from Hippocrates to the third millennium. Br J Ophthalmol. 2003;87(9):1175-1183. doi: 10.1136/bjo.87.9.1175.
  89. Vrioni G, Kalogeropoulos C, Gartzonika C, et al. Usefulness of Herpes Consensus PCR methodology to routine diagnostic testing for herpesviruses infections in clinical specimens. Virol J. 2007;4:59. doi: 10.1186/1743-422X-4-59.
  90. Wensing B, de Groot-Mijnes JD, Rothova A. Necrotizing and nonnecrotizing variants of herpetic uveitis with posterior segment involvement. Arch Ophthalmol. 2011;129(4):403-408. doi: 10.1001/archophthalmol.2010.313.
  91. Yang P, Fang W, Huang X, et al. Alterations of aqueous flare and cells detected by laser flare-cell photometry in patients with Behcet's disease. Int Ophthalmol. 2010;30(5):485-9. doi: 10.1007/s10792-008-9229-z.
  92. Yoser SL, Forster DJ, Rao NA. Systemic viral infections and their retinal and choroidal manifestations. Surv Ophthalmol. 1993;37(5):313-352. doi: 10.1016/0039-6257(93)90064-e.
  93. Yoshizawa C, Saito W, Kase M, Ishida S. Clinical Features of Central Retinal Vein Occlusion With Inflammatory Etiology. Asia Pac J Ophthalmol (Phila). 2012;1(5):270-276. doi: 10.1097/APO.0b013e318266de04.
  94. Ysasaga JE. Frosted Branch Angiitis With Ocular Toxoplasmosis. Arch Ophthalmol. 1999;117(9):1260. doi: 10.1001/archopht.117.9.1260.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать
2. Рис. 1. Патогенез окклюзии вен сетчатки на фоне нейроретиноваскулита

Скачать (71KB)
Метаданные

© Тульцева С.Н., Лисочкина А.Б., Титаренко А.И., Тургель В.А., 2018

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution 4.0 International License.
 


Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах